Structures by: Ouattara M.
Total: 4
1-(2,7-Dimethylimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-(1,3-dithiolan-2-ylidene)ethanone monohydrate
C14H14N2OS2,H2O
Acta Crystallographica Section E (2019) 75, 12 1934-1939
a=28.3247(7)Å b=28.3247(7)Å c=7.2820(2)Å
α=90° β=90° γ=90°
1-(1H-Benzimidazol-2-yl)-3-(3-chlorophenyl)prop-2-en-1-one
C16H11Cl1N2O1
Acta Crystallographica Section E (2007) 63, 12 o4761-o4761
a=9.629(2)Å b=5.617(5)Å c=24.657(4)Å
α=90° β=92.379(9)° γ=90°
1-(2-Methylimidazo[1,2-<i>a</i>]pyridin-3-yl)-3,3-bis(methylsulfanyl)prop- 2-enone monohydrate
C13H14N2OS2,H2O
Acta Crystallographica Section E (2009) 65, 7 o1698-o1699
a=5.14050(10)Å b=17.7653(3)Å c=31.3919(6)Å
α=90° β=90° γ=90°
3-(4-Fluorophenyl)-1-(2-methylimidazo[1,2-<i>a</i>]pyridin-3-yl) prop-2-en-1-one
C17H13F1N2O1
Zeitschrift für Kristallographie - New Crystal Structures (2009) 224, 1 81
a=6.7597(2)Å b=28.4154(8)Å c=7.3112(2)Å
α=90° β=106.4720(10)° γ=90°